D-0007-2025 Class II Ongoing

Recalled by Advanced Accelerator Applications USA, Inc. — Millburn, NJ

FDA drug recall D-0007-2025 was initiated by Advanced Accelerator Applications USA, Inc. on Sep 23, 2024 and is designated Class II. Reason for recall: CGMP deviations The recall status is ongoing. Affected quantity: 99 doses.

Recall details

Product Type
Drugs
Report Date
Oct 9, 2024
Initiation Date
Sep 23, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
99 doses

Product description

Pluvicto, 1000 MBq/mL (27 mCi/mL), lutetium, LU 177, vipivotide tetraxetan injection, Single-dose vial, Sterile, Manufacturer Advanced Accelerator Applications, 57 E. Willow Street, NJ 07041, Millburn USA. NDC 69488-0010-61

Reason for recall

CGMP deviations

Distribution pattern

FL, MA, NJ, NY, PA, and VA

Code information

Lot#: LPS240919B-16, 24-Sep-2024 Lot#: LPS240920B-16, 25-Sep-2024 Lot#: LPS240920C-16, 25-Sep-2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0007-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0007-2025. Report a data issue: hello@regdatalab.com.